The MEA ocular implants market size is forecasted to grow at a steady rate between 2022 to 2027.
The rising aging population, fostering correction cases of vision among children and adults, and advanced technologies with the latest equipment available in these regions are majorly driving the ocular implants market. Cases of cataracts, particularly in aging people aged above 65 years of age, are significantly growing in the Middle East and Africa, further estimated to accelerate the market growth. The growing awareness among the people and government initiatives towards vision care management are likely to project the ocular implants market growth in the MEA during the assessment period.
The shortage of experienced eye professionals required at the time of treatment impedes the market growth in the region. Hurdles concerned with the implantation and post-implantation are limiting the market growth during the period. Side-effects which may arise during the time of eye implants are hindering the ocular implants market growth. Product reproduction of ocular implants is hampering the growth.
This research report on the MEA Ocular Implants Market has been segmented and sub-segmented into the following categories:
By Implant Type:
Based on the implant type, the glaucoma implants segment holds a significant share of the market revenue.
By Application:
Based on application, the Glaucoma surgery segment accounts for a considerable market share.
By End User:
By Region:
Some of the major companies dominating the MEA ocular implants market by their products and services include Bausch & Lomb, Alcon, Carl Zeiss, Johnson & Johnson, MORCHER GmbH, and STAAR Surgical.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]